- Home
- ADPT vs MBC Comparison
ADPT vs MBC Comparison
Compare ADPT & MBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADPT
- MBC
- Stock Information
- Founded
- ADPT 2009
- MBC 1954
- Country
- ADPT United States
- MBC United States
- Employees
- ADPT N/A
- MBC N/A
- Industry
- ADPT Biotechnology: Biological Products (No Diagnostic Substances)
- MBC Agricultural Chemicals
- Sector
- ADPT Health Care
- MBC Industrials
- Exchange
- ADPT Nasdaq
- MBC Nasdaq
- Market Cap
- ADPT 1.8B
- MBC 1.6B
- IPO Year
- ADPT 2019
- MBC N/A
- Fundamental
- Price
- ADPT $12.85
- MBC $13.50
- Analyst Decision
- ADPT Strong Buy
- MBC Strong Buy
- Analyst Count
- ADPT 8
- MBC 1
- Target Price
- ADPT $12.38
- MBC $15.00
- AVG Volume (30 Days)
- ADPT 1.8M
- MBC 1.6M
- Earning Date
- ADPT 08-05-2025
- MBC 11-04-2025
- Dividend Yield
- ADPT N/A
- MBC N/A
- EPS Growth
- ADPT N/A
- MBC N/A
- EPS
- ADPT N/A
- MBC 0.72
- Revenue
- ADPT $205,216,000.00
- MBC $2,777,000,000.00
- Revenue This Year
- ADPT $32.76
- MBC $0.13
- Revenue Next Year
- ADPT $15.81
- MBC $3.29
- P/E Ratio
- ADPT N/A
- MBC $18.14
- Revenue Growth
- ADPT 21.60
- MBC 4.05
- 52 Week Low
- ADPT $3.98
- MBC $9.63
- 52 Week High
- ADPT $13.52
- MBC $20.67
- Technical
- Relative Strength Index (RSI)
- ADPT 57.00
- MBC 63.17
- Support Level
- ADPT $12.62
- MBC $12.38
- Resistance Level
- ADPT $13.25
- MBC $13.36
- Average True Range (ATR)
- ADPT 0.55
- MBC 0.45
- MACD
- ADPT -0.05
- MBC -0.00
- Stochastic Oscillator
- ADPT 58.13
- MBC 81.79
About ADPT Adaptive Biotechnologies Corporation
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).
About MBC MasterBrand Inc.
MasterBrand Inc operates as a residential cabinet manufacturer in North America. It offers a comprehensive portfolio of residential cabinetry products for the kitchen, bathroom, and other parts of the home. The firm sells its products throughout the United States and Canada through three primary channels: dealers, retailers and builders.